Zimmer Biomet Holdings (ZBH) Net Cash Flow (QoQ) (2009 - 2026)
Zimmer Biomet Holdings (ZBH) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Zimmer Biomet Holdings | 18.11 Bn | 17.68 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.94% |
| Dec 31, 2025 | -194.91% |
| Sep 30, 2025 | 187.75% |
| Jun 30, 2025 | -198.85% |
| Mar 31, 2025 | 3,441.96% |
| Dec 31, 2024 | -118.36% |
| Sep 30, 2024 | 355.41% |
| Jun 30, 2024 | 278.36% |
| Mar 31, 2024 | -114.72% |
| Dec 31, 2023 | 584.17% |
| Sep 30, 2023 | -421.74% |
| Jun 30, 2023 | 90.50% |
| Mar 31, 2023 | 73.36% |
| Dec 31, 2022 | -205.82% |
| Sep 30, 2022 | 492.91% |
| Jun 30, 2022 | -138.95% |
| Mar 31, 2022 | 125.37% |
| Dec 31, 2021 | -287.22% |
| Sep 30, 2021 | -139.14% |
| Jun 30, 2021 | 462.94% |